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Abstract
Purpose Paraneoplastic retinopathy can be the first
manifestation of systemic malignancy. A subset of
paraneoplastic retinopathy is characterized by nega-
tive-type electroretinography (ERG) without fundus
abnormality. Here we describe the multimodal imag-
ing and clinico-pathological correlation of a unique
case of acute progressive paravascular placoid neu-
roretinopathy with suspected retinal depolarizing
bipolar cell dysfunction preceding the diagnosis of
metastatic small cell carcinoma of the prostate.
Methods ERG was performed according to the
International Society for Clinical Electrophysiology
of Vision standards. Imaging modalities included
near-infrared reflectance, blue-light autofluorescence,
fluorescein and indocyanine green angiographies,
spectral domain optical coherence tomography,
ultra-widefield colour and green-light autofluores-
cence imaging, microperimetry and adaptive optics
imaging. Patient serum was screened for anti-retinal
antibodies using western blotting. Immunostaining
and histological analyses were performed on sections
from human retinal tissues and a patient prostate
biopsy.
Results Serial multimodal retinal imaging,
microperimetry and adaptive optics photography
demonstrated a paravascular distribution of placoid
lesions characterized by hyper-reflectivity within the
outer nuclear layer resembling type 2 acute macular
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neuroretinopathy. There was no visible lesion within
the inner nuclear layer despite electronegative-type
ERG. Six months later, the patient presented with
metastatic small cell carcinoma of the prostate.
Tumour cells were immunopositive for glyceralde-
hyde-3-phosphate dehydrogenase, enolase and recov-
erin as well as neuroendocrine markers. The patient’s
serum reacted to cytoplasmic and nuclear antigens in
the prostate biopsy and in human retina. Anti-retinal
antibodies against several antigens were detected by
both commercial and in-house western blots.
Conclusions A spectrum of autoreactive anti-retinal
antibodies is associated with a unique phenotype of
acute progressive paravascular placoid neuroretinopa-
thy resulting in degeneration of photoreceptor cells,
inner retinal dysfunction and classic electronegative
ERG in paraneoplastic retinopathy. Detailed clinical,
functional and immunological phenotyping of para-
neoplastic retinopathy illustrated the complex mech-
anism of paraneoplastic syndrome.
Keywords Paraneoplastic retinopathy 
Paravascular placoid neuroretinopathy  Cancer-
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Introduction
Autoimmune retinopathy (AIR) can be paraneoplastic
or non-paraneoplastic [1]. Expeditious and compre-
hensive systemic workup is critical for early detection
of underlying malignancy in AIR patients presenting
without a history of cancer. The diagnosis of AIR is
often delayed due to its overlapping clinical phenotype
with inherited retinal diseases and the lack of speci-
ficity of a positive anti-retinal antibody. Therefore, it is
important to recognize the acute clinical features that
are unique to paraneoplastic AIR to minimize delay in
excluding malignancy.
Herein, we describe the multimodal imaging,
electrophysiology, treatment response and immuno-
logical features of a case of acute paraneoplastic AIR
characterized by an atypical macular neuroretinopa-
thy, electronegative-type electroretinography (ERG)
and a range of autoantibodies that react to both




A 59-year-old Caucasian male presented in May 2015
and underwent full ophthalmic examination and auto-
mated visual field test. Informed consent was obtained
for serial multimodal imaging and serum anti-retinal
antibody analysis. The study protocol adhered to the
tenets of the Declaration of Helsinki and was approved
by the Human Research Ethics Office of the University
of Western Australia (RA/4/1/7916).
Clinical assessment
Imaging modalities included near-infrared reflectance
(NIR), blue-light autofluorescence (AF), fluorescein and
indocyanine green angiographies, spectral domain opti-
cal coherence tomography (SD-OCT, Spectralis
HRA ? OCT, Heidelberg Engineering, Heidelberg,
Germany), ultra-widefield colour and green-light AF
imaging (P200Tx, Optos plc, Dunfermline, UK),
microperimetry (MAIA, CenterVue, Padova, Italy) and
adaptive optics (AO) imaging (rtx1 camera, Imagine
Eyes, Orsay, France). Electrophysiology was performed
according to the International Society for Clinical
Electrophysiology of Vision (ISCEV) standards (RETI-
port 3.2, Roland Consult, Brandenburg, Germany).
Human ocular tissues
Human posterior eye cups were obtained from the
Lions Eye Bank, Western Australia. The use of human
tissue for research was approved by the University of
Western Australia Human Research Ethics Office
(Trial number: 2012-090).
Human prostate histology
The tissue was fixed in formalin and embedded in
paraffin, cut at 4 microns and submitted for routine
hematoxylin and eosin staining. Immunohistochem-
istry was performed including appropriate positive and
negative controls.
Immunostaining
Paraffin-embedded human retinal or prostate tumour
sections were heated at 50 C for 1 h. The sections
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were then deparaffinized in xylene and rehydrated in
graded series of ethanol. Heat epitope retrieval was
performed in a rice cooker by boiling the deparaf-
finized sections for 20 min in antigen retrieval buffer
(10 mM Sodium Citrate, 0.05% Tween20, pH 6). The
sections in the buffer were then cooled on ice. After
washing with TBST (50 mM Tris–HCl, 150 mM
NaCl, 0.05% Tween20), sections were blocked for
1–2 h at room temperature with tris-buffered saline
(TBS, 50 mM Tris–HCl, 150 mM NaCl) containing
10% normal goat serum and 1% BSA. The sections
were then probed at 4 C overnight with human serum
(1:50), rabbit anti-recoverin (1:50), rabbit anti-synap-
tophysin (1:200), rabbit anti-Ki67 (1:200), mouse anti-
GAPDH (1:100) or mouse anti-alpha-enolase (1:100)
in TBS/1% BSA. After five TBS washes, sections
were incubated with DAPI (1ug/ml) and goat antihu-
man AlexaFluor 488 (1:250), goat anti-rabbit Alexa-
Fluor 488 or AlexaFluor 546 (1:250), anti-mouse
AlexaFluor 546 (1:250) (Invitrogen), correspond-
ingly. Negative controls were performed by omitting
the primary antibody.
Western blotting
Human retinal tissue was lysed in RIPA lysis buffer
(Sigma-Aldrich, St. Louis, MO, USA) with 1% protein
inhibitor cocktail (Sigma) followed by shaking at 4 C
for 1 h. The lysate was then centrifuged at 13,000 rpm
for 30 min at 4 C and the supernatant collected and
stored at -20 C. Protein concentration of the lysate
was determined by Bio-Rad Protein Assay (Bio-Rad,
Hercules, CA, USA). Human liver lysates were
obtained from Santa Cruz Biotechnology (Dallas,
TX, USA). Purified recombinant proteins were
obtained from Abcam (Cambridge, England, UK,
GAPDH and alpha-enolase) and Abnova (Taipei,
Taiwan, PNMA2). Twenty micrograms of total pro-
tein from tissue lysates or 1 lg of a purified recom-
binant protein was mixed with Sample Buffer
(Invitrogen, Thermo Fisher, Scientific, Waltham
MA, USA) and heated at 70 C for 10 min before
loading onto a NuPAGE 4–12% Bis–Tris gel (Invit-
rogen). Protein samples were separated by gel elec-
trophoresis in 19 MES buffer (Invitrogen) and then
transferred onto a PVDF membrane (Immobilon-FL,
Merck Millipore, Billerica, MA, USA) at 80 V for
90 min in transfer buffer (25 mM Tris, 190 mM
glycine, 20% methanol, pH 8.3). After transfer, the
membrane was incubated with Odyssey Blocking
Buffer (LI-COR, Lincoln, NE, USA) at room temper-
ature for 1 h. The membrane then was incubated with
human serum (1:200) or rabbit anti-recoverin antibody
(1:1000, ab85292, Abcam) in Odyssey Blocking
Buffer plus 0.1% Tween20 at 4 C overnight. After
washing in TBST 3 times, the membrane was incu-
bated with IRDye 800CW goat antihuman IgG
(1:15,000; LI-COR) in Odyssey Blocking Buffer
plus 0.1% Tween20 and 0.01% SDS for 1 h at room
temperature. After 3 TBSTwashes, the membrane was
washed once with TBS without Tween20. The mem-
brane was then imaged at 800 nm wavelength by the
Odyssey Infrared Imager (Model 9120, LI-COR).
Results
The patient presented with a 3-month history of
darkening of vision and delayed adaptation to reduced
ambient light. He had no previous malignancy. Best-
corrected visual acuity on the Early Treatment of
Diabetic Retinopathy Study (ETDRS) chart was 87
and 85 letters in right and left eyes, respectively.
Fundus examination revealed a trace amount of cells
in the vitreous and cuffing of retinal veins adjacent to
the discs in both eyes. Apart from mild pigment
mottling of the retina, there was no discrete retinal
lesion.
Near-infrared reflectance (NIR) showed hypo-re-
flective lesions extending along vascular arcades and
discrete wedge-shaped lesions pointing towards the
fovea in a petalloid pattern. These lesions corre-
sponded to severe thinning of the outer nuclear layer
(ONL) and loss of the interdigitation zone (IDZ)
surrounded by an adjacent region of hyper-reflectivity
within the ONL (Fig. 1). Microperimetry showed
dense scotoma even within the region of preserved
IDZ and cone structures as shown by en face spectral
domain optical coherence tomography (SD-OCT) and
adaptive optics (AO) imaging (Online Resource 1).
These placoid lesions had increased autofluorescence
(AF) signal. Fluorescein angiography showed no
specific features in the early phase. However, the
paravascular and discrete placoid lesions became
hyper-fluorescent in the late phase with segmental
staining of the retinal veins. Indocyanine green






Electrophysiology showed a profoundly reduced
rod-specific (dark adapted, 0.01 cd s/m2) response; an
electronegative (b/a ratio of 0.8) combined rod-cone
ERG, absent oscillatory potentials (dark adapted,
3.0 cd s/m2); reduced and delayed strong-flash a-wave
(dark adapted, 10.0 cd s/m2); a mildly delayed and
reduced 30-Hz flicker ERG; and a markedly delayed
and reduced standard-flash photopic ERG (light
adapted, 3.0 cd/m2) response characterized by a
broadened trough and a sharply rising b-wave
(Fig. 2). Pattern ERG was essentially flat. The large
check visual evoked potential (VEP) was within
normal limits, whereas small check VEP amplitude
and latency were subnormal.
Based on symptoms and clinical and ERG features,
AIR was suspected and serum was collected for
western blot and immunohistochemistry (IHC) by a
commercial laboratory (Ocular Immunology Labora-
tory, Casey Eye Institute OHSU, Portland, Oregon,
US). Systemic workup including thoracic computed
tomography (CT) and abdominal ultrasound showed
no evidence of lymphadenopathy or tumour. Elec-
trolytes, liver function, full blood picture, C-reactive
protein, immunoglobulin subclasses and vitamin A
levels were within normal range. Commercial western
blot revealed anti-retinal antibodies against 36, 44, 60
and 62 kDa retinal proteins. IHC showed only mod-
erate staining of the inner nuclear layer (INL) and
ganglion cell layer (GCL) in human retina.
In the absence of evidence of underlying systemic
malignancy, the diagnosis of presumed non-paraneo-
plastic AIR was made. Given the rapid deterioration in
vision, the patient agreed to receive 3 doses of pulsed
Fig. 2 Electroretinography. Electrophysiology showed pro-
found reduction in the rod-specific response (DA 0.01), reduced
and delayed strong-flash a-wave (DA 10.0) and standard-flash
photopic ERG (LA 3.0). 30 Hz flicker ERG (LA 30 Hz) was
mildly delayed and reduced. There was reduced amplitude and
increased latency in small check visual evoked potentials (PVEP
small), but the large check visual evoked potentials (PVEP
large) were within normal limits. Pattern electroretinogram
(PERG) was essentially flat on presentation, with some recovery
occurring post-steroid treatment
bFig. 1 Retinal imaging and microperimetry. a, b Ultra-wide-
field colour photographs of the right and left eyes showed no
discrete retinal lesions. c, dHowever, there was increased signal
on green autofluorescence in the peripapillary region extending
out along the major vessels. e–j Near-infrared reflectance
imaging showed discrete hypo-reflective wedge-shaped lesions
pointing towards the fovea in a petalloid pattern in both eyes. g–
lBlue autofluorescence images revealed hyper-autofluorescence
along the major vessels, sparing the central macula in both eyes.
m, n Microperimetry revealed dense scotoma (represented by
black dots) affecting the central 20 of the macula in both eyes.
o, p There was photoreceptor layer loss and retinal thinning on
OCTB-scans in the regions of increased autofluorescence due to
unmasking of autofluorescence from the retinal pigment
epithelium. Insert shows hyper-reflective outer nuclear layer
at the margin of these lesions. q, r D-15 colour vision testing
revealed colour deficiency along the deutan axis. s, t There was
profound field defects in both eyes with 24-2 Humphrey visual
field testing. u, v There was progressive reduction in total
macular volumemeasured on OCT volume scans throughout the
follow-up period despite steroid treatment, but retinal sensitiv-




intravenous methylprednisolone followed by slow oral
taper over the subsequent 6 months. Rapid improve-
ment in visual symptoms was noted after pulsed
steroids, and sustained improvement was confirmed
by serial microperimetry over 5 months. However,
retinal thinning progressed and paravascular lesions
expanded (Online Resource 3).
At 6 months after diagnosis of presumed non-
paraneoplastic AIR, the patient presented with urinary
obstruction and low back pain. Although serum tumour
antigen levels (prostate specific antigen, alpha-fetopro-
tein, CA19-9 and carcinoembryonic antigen) were
within normal limits, C-reactive protein was 256
(normal\10) mg/L and creatinine had risen to 275
(normal: 60–110) lmol/L. CT abdomen and pelvis
demonstrated bilateral hydroureter due to obstruction at
the level of prostate and bladder, enlarged pelvic lymph
nodes and vertebral body fractures at T11 and L2.
Nephrostomy was performed, and transurethral biopsy
of the prostate showed high-grade small cell neuroen-
docrine tumour (NET, Online Resource 4). The patient
received palliative radiation therapy to spinal metas-
tases and carboplatin/etoposide chemotherapy. He died
from metastatic carcinoma in May 2016.
Our in-house retinal IHC staining showed
immunoreactivity of the patient’s serum to nuclear
antigens within the ONL, INL and GCL. Weak
immunoreactivity was also detected in the outer
plexiform layer (OPL) and in the cytoplasm of cells
in the GCL (Fig. 3a, d–f). In contrast, IHC using serum
from an age- and sex-matched control subject failed to
label human retinal sections (Fig. 3b, g).
Immunostaining of prostate tumour sections
demonstrated expression of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), recoverin, alpha-
enolase and synaptophysin in NET cells (Fig. 3h–k).
They also expressed nuclear and perinuclear antigens
recognized by immunoglobulin (Ig)-G antibodies
present in patient serum, but not in serum from a
control subject (Fig. 3l–o).
We further investigated the presence of anti-retinal
antibodies in the patient’s serum by western blotting.
IgG antibodies present in the patient’s serum labelled
multiple bands on western blots containing human
retinal protein lysates. In contrast, no significant
immunoreactivity was detected in human liver protein
lysates (Online Resource 5a). The patient’s serum
displayed immunoreactivity to recombinant GAPDH
(38 kDa) and alpha-enolase (45 kDa) proteins, but not
to paraneoplastic nuclear Ma2 protein (40 kDa) (On-
line Resource 5b).
Discussion
We have described the multimodal imaging and
immunological features of an acute clinical syndrome
characterized by progressive paravascular and placoid
neuroretinopathy with negative-type ERG in a patient
who subsequently developed NET of the prostate and
serum autoantibodies against nuclear and cytoplasmic
antigens within the retina.
Previous multimodal imaging studies of established
cancer-associated retinopathy (CAR) describe diffuse
perimacular outer retinal atrophy on SD-OCT and ring
hyper-autofluorescence surrounded by diffuse hypo-
autofluorescence closely resembling rod-cone dystro-
phy [2–7]. In contrast, our case illustrated acute
lesions characterized by hyper-reflective infiltrates
within the ONL followed rapidly by loss of the EZ and
thinning of the ONL. Although these lesions resemble
acute macular neuroretinopathy, they were more
numerous and extended from the peripapillary region
along major vessels. The reduced NIR signal and
increased AF within these lesions can be explained by
the loss of EZ and photopigment with unmasking of
retinal pigment epithelium AF. Although foveal EZ
and visual acuity were preserved, mesopic
microperimetry demonstrated dense scotoma within
the foveal region. The recovery of mesopic sensitivity
with systemic steroid suggests that an immune-medi-
ated process against the inner retina may be respon-
sible for visual field loss.
Further support for concurrent inner retinal dys-
function is the presence of negative-type ERG, which
is more typically seen in melanoma-associated
retinopathy (MAR) although it has also been described
in patients with CAR [8–11]. However, these reported
CAR cases had no fundus abnormality except for
segmental periphlebitis, similar to the typical MAR
phenotype. Our case illustrated distinct ERG features
that resemble complete congenital stationary night
blindness including an essentially flat rod-specific
ERG response and square-wave appearance of the
single flash photopic ERG due to a delayed and
sharply rising b-wave [12]. These features are consis-
tent with depolarizing or ON-bipolar cell dysfunction.
The reduced and delayed a-wave suggests additional
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photoreceptor dysfunction, and therefore, recording of
the ON- and OFF-responses to long-flash stimulation
is required to conclude that the post-receptoral ON-
pathway is more severely affected than the OFF-
pathway. Unfortunately, this was not performed on our
patient and is a limitation of the ISCEV standard full-
field ERG protocol. It is thus a recommendation of this
study that future revision of the standard protocol
Fig. 3 Immunostaining of human retina and prostate tumour
sections. a–g Human retinal IHC was performed using patient
serum (a, d–f) or serum from an age- and sex-matched control
(b, g). Negative controls stained with the antihuman IgG-AF488
secondary antibody alone were performed in parallel (c). Retinal
sections were counterstained for nuclei with DAPI (blue signal).
Patient IgG antibodies labelled nuclei in the ONL (d), INL
(e) and GCL (f, green signal). Additional immunolabelling was
detected in the OPL (d) and in cell bodies of the GCL (f). No
immunolabelling was detected in retinal sections stained with
control serum (b, g) or in negative controls (c) Scale bars in a–
c indicate 100 lm. h–o Patient prostate biopsy sections were
examined by H&E staining (h) or immunostaining (i–o). SCC
cells displayed immunoreactivity to antibodies specific for
GAPDH (I), alpha-enolase (j), recoverin (k) as well as IgG
antibodies patient (l–n) but not control (o) serum. Patient serum
IgGs labelled synaptophysin positive SCC cells (n) and




includes long-flash recordings in patients where a
negative-type ERG is revealed. Preserved VEP indi-
cated no significant paraneoplastic optic neuropathy.
The unusual combination of negative-type ERG and
neuroretinopathy on OCT in this case of CAR points to
both inner and outer retinopathies. These clinical
features are supported by IHC findings, which demon-
strated binding of anti-retinal autoantibodies in the
patient’s serum to cells in the GCL, INL and ONL of
the retina.
The patient’s serum contained IgG antibodies that
recognized antigens present in both the prostate NET
cells and the human retina (Fig. 3). Western blotting
revealed a number of potential antigens present in
human retinal protein lysates, two of which were
identified as GAPDH and alpha-enolase (Online
Resource 5). Both of these antibodies have previously
been associated with CAR [13] and were expressed by
NET cells in the prostate (Fig. 3i, j). NET cells also
expressed the 23-kDa retinal protein recoverin
(Fig. 3k). Western blotting of retinal lysates demon-
strated patient IgG immunoreactivity to a 23-kDa
band. This band was shown to comigrate with
recoverin immunoreactivity, suggesting anti-recov-
erin antibodies may have also been present (Online
Resource 5). However, western blotting against a
purified recoverin protein is necessary to verify this
observation. Together, these results suggest a complex
systemic immune response may be recruited against a
variety of antigens commonly expressed by retinal and
NET cells.
In conclusion, a spectrum of autoreactive antibod-
ies is associated with a unique phenotype of acute
progressive paravascular placoid neuroretinopathy
resulting in degeneration of photoreceptor cells,
suspected dysfunction of depolarizing bipolar cells
and classic negative-type ERG in paraneoplastic
retinopathy. Detailed clinical, functional and immuno-
logical phenotyping of paraneoplastic retinopathy
illustrates the complex mechanism of paraneoplastic
syndrome.
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